{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:48:12Z","timestamp":1791301692377,"version":"4.1.0"},"reference-count":46,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,3,20]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>In SMZL, the quality of BM stromal microenvironment predicts disease progression. CD40-CD40L-mediated interactions between mast cells and BM mesenchymal cells engender proinflammatory conditions within SMZL infiltrates.<\/jats:p>","DOI":"10.1182\/blood-2013-04-497271","type":"journal-article","created":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T03:42:45Z","timestamp":1390448565000},"page":"1836-1849","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":38,"title":["Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma"],"prefix":"10.1182","volume":"123","author":[{"given":"Giovanni","family":"Franco","sequence":"first","affiliation":[{"name":"Hematology Unit with Bone Marrow Transplantation and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Guarnotta","sequence":"additional","affiliation":[{"name":"Human Pathology Section, Department of Health Science, University of Palermo, Palermo, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Frossi","sequence":"additional","affiliation":[{"name":"Department of Medical and Biological Sciences, University of Udine, Udine, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Paolo","family":"Piccaluga","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncological Sciences \u201cL. e A. Ser\u00e0gnoli,\u201d University of Bologna School of Medicine, Bologna, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Boveri","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, University of Pavia Medical School, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Foundation, Pavia, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Gulino","sequence":"additional","affiliation":[{"name":"Human Pathology Section, Department of Health Science, University of Palermo, Palermo, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Fuligni","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncological Sciences \u201cL. e A. Ser\u00e0gnoli,\u201d University of Bologna School of Medicine, Bologna, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Rigoni","sequence":"additional","affiliation":[{"name":"Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Porcasi","sequence":"additional","affiliation":[{"name":"Human Pathology Section, Department of Health Science, University of Palermo, Palermo, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Buffa","sequence":"additional","affiliation":[{"name":"Human Pathology Section, Department of Health Science, University of Palermo, Palermo, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Betto","sequence":"additional","affiliation":[{"name":"Department of Medical and Biological Sciences, University of Udine, Udine, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada Maria","family":"Florena","sequence":"additional","affiliation":[{"name":"Human Pathology Section, Department of Health Science, University of Palermo, Palermo, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Franco","sequence":"additional","affiliation":[{"name":"Human Pathology Section, Department of Health Science, University of Palermo, Palermo, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Iannitto","sequence":"additional","affiliation":[{"name":"Hematology Unit with Bone Marrow Transplantation and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Arcaini","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, University of Pavia Medical School, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo Foundation, Pavia, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano Aldo","family":"Pileri","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncological Sciences \u201cL. e A. Ser\u00e0gnoli,\u201d University of Bologna School of Medicine, Bologna, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Pucillo","sequence":"additional","affiliation":[{"name":"Department of Medical and Biological Sciences, University of Udine, Udine, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Paolo","family":"Colombo","sequence":"additional","affiliation":[{"name":"Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Sangaletti","sequence":"additional","affiliation":[{"name":"Molecular Immunology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Tripodo","sequence":"additional","affiliation":[{"name":"Human Pathology Section, Department of Health Science, University of Palermo, Palermo, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111818215329100_B1","volume-title":"WHO Classification of Tumours of Haemopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008","edition":"4th ed"},{"issue":"7","key":"2019111818215329100_B2","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1182\/blood-2002-07-2216","article-title":"Splenic marginal zone lymphoma.","volume":"101","author":"Franco","year":"2003","journal-title":"Blood"},{"issue":"2","key":"2019111818215329100_B3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1470-2045(03)00981-1","article-title":"Splenic marginal-zone lymphoma: a distinct clinical and pathological entity.","volume":"4","author":"Thieblemont","year":"2003","journal-title":"Lancet Oncol"},{"issue":"2","key":"2019111818215329100_B4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11864-007-0026-0","article-title":"Splenic marginal zone lymphoma with and without villous lymphocytes.","volume":"8","author":"Matutes","year":"2007","journal-title":"Curr Treat Options Oncol"},{"issue":"9","key":"2019111818215329100_B5","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood-2010-09-271437","article-title":"How I diagnose and treat splenic lymphomas.","volume":"117","author":"Iannitto","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2019111818215329100_B6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1365-2559.1996.d01-536.x","article-title":"Intrasinusoidal bone marrow infiltration: a possible hallmark of splenic lymphoma.","volume":"29","author":"Franco","year":"1996","journal-title":"Histopathology"},{"issue":"11","key":"2019111818215329100_B7","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1097\/PAS.0b013e318271243d","article-title":"Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology?","volume":"36","author":"Ponzoni","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2019111818215329100_B8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/annonc\/mdn563","article-title":"Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients.","volume":"20","author":"Boveri","year":"2009","journal-title":"Ann Oncol"},{"issue":"5","key":"2019111818215329100_B9","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","article-title":"Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome.","volume":"117","author":"Rinaldi","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2019111818215329100_B10","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","article-title":"Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.","volume":"116","author":"Salido","year":"2010","journal-title":"Blood"},{"issue":"9","key":"2019111818215329100_B11","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1002\/cncr.20596","article-title":"Splenic marginal zone lymphoma with or without villous lymphocytes. Hematologic findings and outcomes in a series of 57 patients.","volume":"101","author":"Iannitto","year":"2004","journal-title":"Cancer"},{"issue":"12","key":"2019111818215329100_B12","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","article-title":"Splenic marginal zone lymphoma: a prognostic model for clinical use.","volume":"107","author":"Arcaini","year":"2006","journal-title":"Blood"},{"issue":"10","key":"2019111818215329100_B13","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1158\/0008-5472.CAN-12-0122","article-title":"Tumor microenvironment complexity: emerging roles in cancer therapy.","volume":"72","author":"Swartz","year":"2012","journal-title":"Cancer Res"},{"issue":"8","key":"2019111818215329100_B14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nrclinonc.2011.31","article-title":"The bone marrow stroma in hematological neoplasms\u2014a guilty bystander.","volume":"8","author":"Tripodo","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"2019111818215329100_B15","doi-asserted-by":"crossref","first-page":"138079","DOI":"10.1155\/2012\/138079","article-title":"Microenvironment-centred dynamics in aggressive B-cell lymphomas.","volume":"2012","author":"Cacciatore","year":"2012","journal-title":"Adv Hematol"},{"issue":"6","key":"2019111818215329100_B16","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood-2005-04-1565","article-title":"Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).","volume":"106","author":"Farinha","year":"2005","journal-title":"Blood"},{"issue":"10","key":"2019111818215329100_B17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin\u2019s lymphoma.","volume":"362","author":"Steidl","year":"2010","journal-title":"N Engl J Med"},{"issue":"7","key":"2019111818215329100_B18","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3324\/haematol.2012.073080","article-title":"The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation.","volume":"98","author":"Maffei","year":"2013","journal-title":"Haematologica"},{"issue":"14","key":"2019111818215329100_B19","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1182\/blood-2009-10-250126","article-title":"Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells.","volume":"115","author":"Merluzzi","year":"2010","journal-title":"Blood"},{"issue":"8","key":"2019111818215329100_B20","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/annonc\/mdl109","article-title":"Mast cells in Waldenstrom\u2019s macroglobulinemia support lymphoplasmacytic cell growth through CD154\/CD40 signaling.","volume":"17","author":"Tournilhac","year":"2006","journal-title":"Ann Oncol"},{"issue":"16","key":"2019111818215329100_B21","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/blood-2009-06-225326","article-title":"The microenvironment in mature B-cell malignancies: a target for new treatment strategies.","volume":"114","author":"Burger","year":"2009","journal-title":"Blood"},{"issue":"9","key":"2019111818215329100_B22","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1158\/0008-5472.CAN-08-4173","article-title":"CD38\/CD31, the CCL3 and CCL4 chemokines, and CD49d\/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.","volume":"69","author":"Zucchetto","year":"2009","journal-title":"Cancer Res"},{"issue":"13","key":"2019111818215329100_B23","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1158\/0008-5472.CAN-07-6621","article-title":"Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.","volume":"68","author":"Serafini","year":"2008","journal-title":"Cancer Res"},{"issue":"13","key":"2019111818215329100_B24","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1158\/0008-5472.CAN-09-0266","article-title":"Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin\u2019s lymphoma.","volume":"69","author":"Yang","year":"2009","journal-title":"Cancer Res"},{"issue":"2","key":"2019111818215329100_B25","doi-asserted-by":"crossref","first-page":"792","DOI":"10.2353\/ajpath.2010.091286","article-title":"Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma.","volume":"177","author":"Tripodo","year":"2010","journal-title":"Am J Pathol"},{"issue":"2","key":"2019111818215329100_B26","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/1097-0142(20010115)91:2<294::AID-CNCR1001>3.0.CO;2-W","article-title":"Splenectomy influences bone marrow infiltration in patients with splenic marginal zone cell lymphoma with or without villous lymphocytes.","volume":"91","author":"Franco","year":"2001","journal-title":"Cancer"},{"issue":"1","key":"2019111818215329100_B27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3324\/haematol.13598","article-title":"CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis.","volume":"94","author":"Tripodo","year":"2009","journal-title":"Haematologica"},{"issue":"6667","key":"2019111818215329100_B28","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","article-title":"CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells.","volume":"391","author":"Henn","year":"1998","journal-title":"Nature"},{"issue":"1","key":"2019111818215329100_B29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0090-1229(95)90135-3","article-title":"CD40 expression by human fibroblasts.","volume":"77","author":"Fries","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"issue":"9","key":"2019111818215329100_B30","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1182\/blood-2003-10-3438","article-title":"Interleukin-6 deficiency affects bone marrow stromal precursors, resulting in defective hematopoietic support.","volume":"103","author":"Rodr\u00edguez","year":"2004","journal-title":"Blood"},{"issue":"1","key":"2019111818215329100_B31","first-page":"3","article-title":"Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice.","volume":"79","author":"Ward","year":"1999","journal-title":"Lab Invest"},{"issue":"8","key":"2019111818215329100_B32","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1073\/pnas.1222570110","article-title":"Conditional inactivation of p53 in mature B cells promotes generation of nongerminal center-derived B-cell lymphomas.","volume":"110","author":"Gostissa","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"2019111818215329100_B33","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2011-06-359166","article-title":"Alteration of BIRC3 and multiple other NF-\u03baB pathway genes in splenic marginal zone lymphoma.","volume":"118","author":"Rossi","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2019111818215329100_B34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/10428190500272556","article-title":"Immunophenotypic profile and role of adhesion molecules in splenic marginal zone lymphoma with bone marrow involvement.","volume":"47","author":"Florena","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"2019111818215329100_B35","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrclinonc.2009.169","article-title":"Gamma-delta T-cell lymphomas.","volume":"6","author":"Tripodo","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"2019111818215329100_B36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/path.1705","article-title":"CD10+ stromal cells form B-lymphocyte maturation niches in the human bone marrow.","volume":"205","author":"Torlakovic","year":"2005","journal-title":"J Pathol"},{"issue":"6","key":"2019111818215329100_B37","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.immuni.2006.10.016","article-title":"Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches.","volume":"25","author":"Sugiyama","year":"2006","journal-title":"Immunity"},{"issue":"5909","key":"2019111818215329100_B38","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1126\/science.1164390","article-title":"Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells.","volume":"322","author":"Colmone","year":"2008","journal-title":"Science"},{"key":"2019111818215329100_B39","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fimmu.2012.00120","article-title":"Mast cell: an emerging partner in immune interaction.","volume":"3","author":"Gri","year":"2012","journal-title":"Front Immunol"},{"issue":"4","key":"2019111818215329100_B40","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1158\/0008-5472.CAN-11-3110","article-title":"The dark side of mast cell-targeted therapy in prostate cancer.","volume":"72","author":"Pittoni","year":"2012","journal-title":"Cancer Res"},{"issue":"2","key":"2019111818215329100_B41","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1046\/j.1365-2559.2001.01173.x","article-title":"Tryptase-positive mast cells accompany lymphocytic as well as lymphoplasmacytic lymphoma infiltrates in bone marrow trephine biopsies.","volume":"39","author":"Wilkins","year":"2001","journal-title":"Histopathology"},{"issue":"3","key":"2019111818215329100_B42","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1046\/j.1365-2141.2001.02977.x","article-title":"Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin\u2019s disease.","volume":"114","author":"Molin","year":"2001","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111818215329100_B43","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1365-2222.2010.03685.x","article-title":"Bone marrow stromal cells inhibit mast cell function via a COX2-dependent mechanism.","volume":"41","author":"Brown","year":"2011","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"2019111818215329100_B44","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.immuni.2008.08.018","article-title":"CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction.","volume":"29","author":"Gri","year":"2008","journal-title":"Immunity"},{"issue":"13","key":"2019111818215329100_B45","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1182\/blood-2009-05-220004","article-title":"Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40\/OX40L axis toward Th17-cell differentiation.","volume":"114","author":"Piconese","year":"2009","journal-title":"Blood"},{"issue":"10","key":"2019111818215329100_B46","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1182\/blood-2012-03-415638","article-title":"Mast cells play a protumorigenic role in primary cutaneous lymphoma.","volume":"120","author":"Rabenhorst","year":"2012","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/123\/12\/1836\/1374844\/1836.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/123\/12\/1836\/1374844\/1836.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T13:40:51Z","timestamp":1597412451000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/123\/12\/1836\/32717\/Bone-marrow-stroma-CD40-expression-correlates-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,20]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,3,20]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2013-04-497271","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,20]]}}}